Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England.

ABSTRACT:

Introduction

We sought to evaluate the cost-effectiveness of newborn screening (NBS) versus no NBS for 5q spinal muscular atrophy (SMA) in England.

Methods

A cost-utility analysis using a combination of decision tree and Markov model structures was developed to estimate the lifetime health effects and costs of NBS for SMA, compared with no NBS, from the perspective of the National Health Service (NHS) in England. A decision tree was designed to capture NBS outcomes, and Markov modeling was used to project long-term health outcomes and costs for each patient group following diagnosis. Model inputs were based on existing literature, local data, and expert opinion. Sensitivity and scenario analyses were conducted to assess the robustness of the model and the validity of the res

SUBMITTER: Weidlich D 

PROVIDER: S-EPMC10310612 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature